HUB Investment Partners
NVCR icon

HUB Investment Partners’s NovoCure NVCR Stock Holding History

HUB Investment Partners’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Sell
16,342
-292
-2% -$4.42K ﹤0.01% 1097
2026
Q1 		$181K Buy
16,634
+3,094
+23% +$38.6K ﹤0.01% 1010
2025
Q4 		$175K Buy
+13,540
New +$174K ﹤0.01% 864

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Quantinno Capital Management
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

HUB Investment Partners's NVCR Position: Q2 2026 in Review

HUB Investment Partners reduced its NovoCure (NVCR) stake by 1.8% in Q2 2026, selling an estimated $4.42K and leaving 16,342 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #1097.

HUB Investment Partners first reported a position in NVCR in Q4 2025 and has held it in 3 quarters since. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • HUB Investment Partners held 16,342 shares of NovoCure worth $248K as of Q2 2026.
  • HUB Investment Partners sold 292 NovoCure shares in Q2 2026, an estimated $4.42K.
  • NovoCure made up ﹤0.01% of HUB Investment Partners's portfolio in Q2 2026, its #1097 holding.
  • HUB Investment Partners first reported a position in NovoCure in Q4 2025 and has held it in 3 quarters since.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.